LIVE

CMPS

COMPASS Pathways plc

CMPS

NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $1.3B

$13.62

▲ +2.48%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$3.24 - $15.40

P/E

-6.36

Fwd P/E

-9.80

Beta

2.51

Div Yield

0.00%

Avg Vol

4.2M

Shares Out

96.1M

Mkt Cap

$1.3B

Price action

Price chart

Up 293.2% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Proprietary psilocybin formulation and delivery system (COMP360)
  • Advanced clinical trial data and regulatory pathway expertise
  • Integrated therapeutic protocol combining drug and psychotherapy
  • Strong intellectual property portfolio protecting novel compounds and methods
▼

Bear Case

1 risk

  • High volatility (beta 2.5). Larger-than-normal price swings expected.

Growth

Revenue decline expected

Progression through FDA clinical trials toward regulatory approval

Value

Deep value opportunity - significant discount to Healthcare Facilities peers

Momentum

Hot

+129.5% over 3m

Quality

Loss-making

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 7, 2026

“
Q2 26 RECAP

MAY 13, 2026

Reported EPS of -$0.71 vs -$0.45 consensus (-57.8% surprise).

EPS miss

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-57.8%

Next: May 7, 2026

Revenue trend · last 8Q

—

—

—

—

—

—

—

—

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$0

$0

$0

$0

$0

$0

$0

$0

Margins · last 8Q

No margin history available.

View full earnings history →

Wall Street consensus

6 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

6

100%

Hold

0%

Sell

0%

Median Price Target

$18.00

▲ +32.2% vs $13.62

Low $17.00
Median $18.00
High $20.00

Latest: Maxim Group · $20.00 · May 15, 2026

4 analysts covering

View full analyst page →

vs Industry

How CMPS stacks vs Medical - Care Facilities

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.